Little Higgses from an Antisymmetric Condensate

We construct an SU(6)/Sp(6) non-linear sigma model in which the Higgses arise as pseudo-Goldstone bosons. There are two Higgs doublets whose masses have no one-loop quadratic sensitivity to the cutoff of the effective theory, which can be at around 10 TeV. The Higgs potential is generated by gauge and Yukawa interactions, and is distinctly different from that of the minimal supersymmetric standard model. At the TeV scale, the new bosonic degrees of freedom are a single neutral complex scalar and a second copy of SU(2)xU(1) gauge bosons. Additional vector-like pairs of colored fermions are also present.Comment: 13 page

RS1, Custodial Isospin and Precision Tests

We study precision electroweak constraints within a RS1 model with gauge fields and fermions in the bulk. The electroweak gauge symmetry is enhanced to SU(2)_L \times SU(2)_R \times U(1)_{B-L}, thereby providing a custodial isospin symmetry sufficient to suppress excessive contributions to the T parameter. We then construct complete models, complying with all electroweak constraints, for solving the hierarchy problem, without supersymmetry or large hierarchies in the fundamental couplings. Using the AdS/CFT correspondence our models can be interpreted as dual to a strongly coupled conformal Higgs sector with global custodial symmetry, gauge and fermionic matter being fundamental fields external to the CFT. This scenario has interesting collider signals, distinct from other RS models in the literature.Comment: 32 pages, 6 figures, latex2e, minor changes, references adde

The management of diabetic ketoacidosis in children

The object of this review is to provide the definitions, frequency, risk factors, pathophysiology, diagnostic considerations, and management recommendations for diabetic ketoacidosis (DKA) in children and adolescents, and to convey current knowledge of the causes of permanent disability or mortality from complications of DKA or its management, particularly the most common complication, cerebral edema (CE). DKA frequency at the time of diagnosis of pediatric diabetes is 10%–70%, varying with the availability of healthcare and the incidence of type 1 diabetes (T1D) in the community. Recurrent DKA rates are also dependent on medical services and socioeconomic circumstances. Management should be in centers with experience and where vital signs, neurologic status, and biochemistry can be monitored with sufficient frequency to prevent complications or, in the case of CE, to intervene rapidly with mannitol or hypertonic saline infusion. Fluid infusion should precede insulin administration (0.1 U/kg/h) by 1–2 hours; an initial bolus of 10–20 mL/kg 0.9% saline is followed by 0.45% saline calculated to supply maintenance and replace 5%–10% dehydration. Potassium (K) must be replaced early and sufficiently. Bicarbonate administration is contraindicated. The prevention of DKA at onset of diabetes requires an informed community and high index of suspicion; prevention of recurrent DKA, which is almost always due to insulin omission, necessitates a committed team effort

Findings from Denosumab (Prolia (R)) Postmarketing Safety Surveillance for Serious Infections

Bone and mineral researc